Zhejiang Medicine (600216.SH) has announced a forecasted increase, expecting a net profit of 1.039-1.246 billion yuan in 2024, an increase of 141.83%-190.01% compared to the previous year.

18:59 22/01/2025

Zhejiang Medicine (600216.SH) has issued an announcement, the company is expected to achieve a net profit attributable to the parent company in the year of 2024...

Zhejiang Medicine (600216.SH) issued an announcement, stating that the company is expected to achieve a net profit attributable to the owners of the parent company of 1.039 billion to 1.246 billion yuan in 2024. Compared with the same period last year, it will increase by 609.36 million to 816.36 million yuan, a year-on-year increase of 141.83% to 190.01%.

HK Stock Market Move | In the afternoon, data center stocks rose, with GDS-SW (09698) rising over 16% after performance, and SUNEVISION (01686) rising over 5%.

HK Stock Market Move | WEIMOB INC (02013) is currently up nearly 7%, with adjusted net profit turning positive for the first time in recent years. Annual revenue related to AI has surpassed one billion yuan.

Goldman Sachs: Initiates coverage of Montage Technology (06809) with a "buy" rating and a target price of HK$268.

HK Stock Market Move | In the afternoon, data center stocks rose, with GDS-SW (09698) rising over 16% after performance, and SUNEVISION (01686) rising over 5%.

Goldman Sachs: Initiates coverage of Montage Technology (06809) with a "buy" rating and a target price of HK$268.